Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

19 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q1 2024.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.66M shares of 384M outstanding shares and own 0.69% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.24M shares), Ikarian Capital, LLC (213K shares), TWO SIGMA INVESTMENTS, LP (40K shares), TWO SIGMA ADVISERS, LP (37.8K shares), KESTRA PRIVATE WEALTH SERVICES, LLC (31.2K shares), BOOTHBAY FUND MANAGEMENT, LLC (26.5K shares), TWO SIGMA SECURITIES, LLC (26.2K shares), RHUMBLINE ADVISERS (18.6K shares), GEODE CAPITAL MANAGEMENT, LLC (11.7K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.5K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.